CLINICAL_TRIALS
trial_result
· 2019-07-30
Clinical Trial Update: Extension in AS: Sustainability of Benefits, Safety and Tolerability [Phase 3]
Summary
Phase 3 extension study update on sustainability of benefits, safety, and tolerability for AS (ankylosing spondylitis).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Spondylitis, Ankylosing | Phase 3 | Status: COMPLETED | Results posted: 2019-07-30